Alerts will be sent to your verified email
Verify Email
KIMIABL
|
Kimia Biosciences
|
Coral Laboratories
|
Alpa Lab
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Unclassified
|
|||
|
R&D as a % of Total Sales
|
4.79 % | n/a | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
-352.38 % | 6.99 % | 8.11 % |
|
5yr average Equity Multiplier
|
65.1 | 1.2 | 1.24 |
|
5yr Average Asset Turnover Ratio
|
1.17 | 0.47 | 0.66 |
|
5yr Avg Net Profit Margin
|
-2.03 % | 12.64 % | 10.22 % |
|
Price to Book
|
0.0 | 1.09 | 1.22 |
|
P/E
|
23.38 | 9.07 | 10.7 |
|
5yr Avg Cash Conversion Cycle
|
28.76 Days | 26.14 Days | 119.67 Days |
|
Inventory Days
|
94.07 Days | 79.65 Days | 52.46 Days |
|
Days Receivable
|
101.18 Days | 112.59 Days | 147.5 Days |
|
Days Payable
|
144.79 Days | 147.17 Days | 97.89 Days |
|
5yr Average Interest Coverage Ratio
|
0.28 | 114.88 | 75.25 |
|
5yr Avg ROCE
|
-0.98 % | 8.79 % | 10.84 % |
|
5yr Avg Operating Profit Margin
|
1.32 % | 11.85 % | 7.49 % |
|
5 yr average Debt to Equity
|
29.7 | 0.03 | 0.02 |
|
5yr CAGR Net Profit
|
n/a | 17.24 % | 55.43 % |
|
5yr Average Return on Assets
|
-2.12 % | 5.83 % | 6.5 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
74.94 % | 71.51 % | 57.29 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Kimia Biosciences
|
Coral Laboratories
|
Alpa Lab
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|